40 related articles for article (PubMed ID: 11723300)
1. AJAP1 expression modulates glioma cell motility and correlates with tumor growth and survival.
Di C; Mladkova N; Lin J; Fee B; Rivas M; Chunsheng K; Bigner D; Adamson DC
Int J Oncol; 2018 Jan; 52(1):47-54. PubMed ID: 29115565
[TBL] [Abstract][Full Text] [Related]
2. Gliomatosis cerebri: clinical characteristics, management, and outcomes.
Chen S; Tanaka S; Giannini C; Morris J; Yan ES; Buckner J; Lachance DH; Parney IF
J Neurooncol; 2013 Apr; 112(2):267-75. PubMed ID: 23341100
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors for patients with gliomatosis cerebri: retrospective analysis of 17 consecutive cases.
Inoue T; Kumabe T; Kanamori M; Sonoda Y; Watanabe M; Tominaga T
Neurosurg Rev; 2010 Apr; 34(2):197-208. PubMed ID: 21301914
[TBL] [Abstract][Full Text] [Related]
4. Gliomatosis cerebri in young patients' report of three cases and review of the literature.
Landi A; Piccirilli M; Mancarella C; Giangaspero F; Salvati M
Childs Nerv Syst; 2011 Jan; 27(1):19-25. PubMed ID: 20376465
[TBL] [Abstract][Full Text] [Related]
5. Gliomatosis cerebri in children. Case report and clinical considerations.
Caroli E; Orlando ER; Ferrante L
Childs Nerv Syst; 2005 Nov; 21(11):1000-3. PubMed ID: 16240166
[TBL] [Abstract][Full Text] [Related]
6. Gliomatosis cerebri: a review of 296 cases from the ANOCEF database and the literature.
Taillibert S; Chodkiewicz C; Laigle-Donadey F; Napolitano M; Cartalat-Carel S; Sanson M
J Neurooncol; 2006 Jan; 76(2):201-5. PubMed ID: 16200347
[TBL] [Abstract][Full Text] [Related]
7. Marked response of gliomatosis cerebri to temozolomide and whole brain radiotherapy.
Mattox AK; Lark AL; Adamson DC
Clin Neurol Neurosurg; 2012 May; 114(4):299-306. PubMed ID: 22341931
[TBL] [Abstract][Full Text] [Related]
8. Temozolomide in malignant gliomas: current use and future targets.
Villano JL; Seery TE; Bressler LR
Cancer Chemother Pharmacol; 2009 Sep; 64(4):647-55. PubMed ID: 19543728
[TBL] [Abstract][Full Text] [Related]
9. Nocardia abscesses mimicking tumor progression in gliomatosis cerebri responding to temozolomide.
Bertero L; Cassoni P; Rudà R
J Neurooncol; 2015 Jan; 121(1):225-7. PubMed ID: 25189790
[No Abstract] [Full Text] [Related]
10. Response to low dose temozolomide in radiation induced gliomatosis cerebri.
Hargrave D; Bouffet E; Gammon J; Becker L; Rutka J; Baruchel S
Med Pediatr Oncol; 2003 Dec; 41(6):562-4. PubMed ID: 14595716
[No Abstract] [Full Text] [Related]
11. Chemotherapy as initial treatment in gliomatosis cerebri: results with temozolomide.
Levin N; Gomori JM; Siegal T
Neurology; 2004 Jul; 63(2):354-6. PubMed ID: 15277636
[TBL] [Abstract][Full Text] [Related]
12. Initial chemotherapy in gliomatosis cerebri.
Sanson M; Cartalat-Carel S; Taillibert S; Napolitano M; Djafari L; Cougnard J; Gervais H; Laigle F; Carpentier A; Mokhtari K; Taillandier L; Chinot O; Duffau H; Honnorat J; Hoang-Xuan K; Delattre JY;
Neurology; 2004 Jul; 63(2):270-5. PubMed ID: 15277619
[TBL] [Abstract][Full Text] [Related]
13. Gliomatosis cerebri: clinical, neurochemical and neuroradiological response to temozolomide administration.
Lodi R; Setola E; Tonon C; Ambrosetto P; Franceschi E; Crinò L; Barbiroli B; Cortelli P
Magn Reson Imaging; 2003 Nov; 21(9):1003-7. PubMed ID: 14684203
[TBL] [Abstract][Full Text] [Related]
14. Possible efficacy of temozolomide in a patient with gliomatosis cerebri.
Benjelloun A; Delavelle J; Lazeyras F; Dietrich PY
Neurology; 2001 Nov; 57(10):1932-3. PubMed ID: 11723300
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]